# Docetaxel in Treating Older Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

> **NCT00227708** · PHASE2 · COMPLETED · sponsor: **UNICANCER** · enrollment: 58 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** docetaxel
- **PROCEDURE:** quality-of-life assessment

## Key facts

- **NCT ID:** NCT00227708
- **Lead sponsor:** UNICANCER
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** —
- **Final completion:** 2006-08-29
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2020-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00227708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00227708, "Docetaxel in Treating Older Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00227708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*